SCHEMBL27166264

SCHEMBL27166264

CCOc1ccc(CC(CO)NCc2ccc(OC)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.48
ADRB3 P13945 1/20 0.48
LMNA P02545 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ACACB O00763 3/20 0.45
ALDH1A1 P00352 2/20 0.45
ALOX12 P18054 1/20 0.45
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
ADRB2 P07550 2/20 0.43
PKM P14618 1/20 0.42
LDHA P00338 1/20 0.42
EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27166267 0.89 ADRB1 (0.47) ADRB1ADRB3LMNAACACBALDH1A1
SCHEMBL27166314 0.89 ADRB1 (0.47) ADRB1ADRB3LMNAACACBALDH1A1
SCHEMBL27166305 0.89 ACACB (0.46) ADRB1ADRB3LMNAACACBALDH1A1
SCHEMBL27166224 0.89 ACACB (0.46) ADRB1ADRB3LMNAACACBALDH1A1
SCHEMBL27166365 0.87 ACACB (0.45) ADRB1ADRB3LMNAMEN1KMT2A
SCHEMBL27166309 0.87 ACACB (0.45) ADRB1ADRB3LMNAMEN1KMT2A
SCHEMBL27166280 0.87 ACACB (0.45) ADRB1ADRB3LMNAMEN1KMT2A
SCHEMBL27166253 0.87 ACACB (0.45) ADRB1ADRB3LMNAMEN1KMT2A
SCHEMBL23802882 0.86 ADRB1 (0.53) ADRB1ADRB3MEN1KMT2AL3MBTL1
SCHEMBL10878607 0.86 ADRB1 (0.53) ADRB1ADRB3MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584251-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING Bayer Aktiengesellschaft (DE) 2025-07-16 EP disclosed
WO-2024052549-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING BAYER AKTIENGESELLSCHAFT (DE) 2024-03-14 WO disclosed
WO-2024052549-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING BAYER AKTIENGESELLSCHAFT (DE) 2024-03-14 WO disclosed
EP-4335840-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING Bayer Aktiengesellschaft (DE) 2024-03-13 EP disclosed